Halozyme Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2013-03-31 | $2.7M | 465k | 5.77 |
| 2012-12-31 | $647k | 97k | 6.70 |
| 2012-09-30 | $213k | 28k | 7.57 |
| 2012-06-30 | $324k | 37k | 8.85 |
| 2012-03-31 | $832k | 65k | 12.76 |
| 2011-09-30 | $272k | 44k | 6.15 |
| 2011-03-31 | $364k | 56k | 6.56 |
| 2010-12-31 | $16k | 2.0k | 7.98 |